Raab W P
Int J Clin Pharmacol Biopharm. 1976 Jul;14(1):44-7.
Experimental investigations were performed to elaborate the immunogenic and anaphylactoid properties of spectinomycin. In guinea-pigs, no allergy against spectinomycin could be elicited. Furthermore, the absence of immunologic cross-reactions between spectinomycin and penicillin could be confirmed. The anaphylactoid activity of spectinomycin was found to be of very low order. No mast cell degranulating action could be observed. The data collected in this study permit the statement that - as far as acute unwanted actions of antibiotics are concerned - spectinomycin is an extremely safe drug.
进行了实验研究以阐明壮观霉素的免疫原性和类过敏特性。在豚鼠中,未引发对壮观霉素的过敏反应。此外,还证实了壮观霉素与青霉素之间不存在免疫交叉反应。发现壮观霉素的类过敏活性非常低。未观察到肥大细胞脱颗粒作用。本研究收集的数据表明,就抗生素的急性不良反应而言,壮观霉素是一种极其安全的药物。